A 24-year-old accountant complains of a white discharge from his breasts. He is most likely experiencing which one of the following?
**Core Concept**
Prolactin is a hormone secreted by the anterior pituitary gland that stimulates milk production in lactating women. However, in non-pregnant, non-lactating individuals, elevated prolactin levels can cause galactorrhea, a condition characterized by the spontaneous flow of milk from the breast. This can be due to a prolactinoma, a type of pituitary adenoma that secretes excess prolactin.
**Why the Correct Answer is Right**
A prolactinoma is a benign tumor of the anterior pituitary gland that secretes excessive amounts of prolactin. This excess prolactin can cause galactorrhea, as seen in the accountant in the question. The tumor's secretory activity can be inhibited by bromocriptine, a dopamine analog that acts as a dopamine agonist, thereby reducing prolactin secretion. This is a well-established treatment for prolactinomas.
**Why Each Wrong Option is Incorrect**
**Option A:** A tumor of the posterior pituitary would not cause galactorrhea, as the posterior pituitary primarily secretes antidiuretic hormone (ADH) and oxytocin (OT), neither of which is directly involved in milk production.
**Option B:** Excessive production of OT in the hypothalamus would not cause galactorrhea, as OT stimulates uterine contractions and milk letdown during lactation, but does not directly stimulate milk production.
**Option C:** Deficient testosterone receptors in the mammary glands would not cause galactorrhea, as testosterone receptors are not directly involved in milk production or galactorrhea.
**Clinical Pearl / High-Yield Fact**
Prolactinomas are the most common type of functioning pituitary adenoma, and bromocriptine is a first-line treatment for managing symptoms. It's essential to consider this diagnosis in any patient presenting with galactorrhea, especially if there are other symptoms such as amenorrhea or infertility in women, or gynecomastia in men.
**✓ Correct Answer: D. A prolactinoma that would decrease its secretory activity in response to bromocriptine (an analog of dopamine)**